LIPOMED AG
LIPOMED AG was included in the global trader database of NBD Trade Data on 2021-02-24. It is the first time for LIPOMED AG to appear in the customs data of the SWITZERLAND，and at present, NBD Customs Data system has included 447 customs import and export records related to it, and among the trade partners of LIPOMED AG, 15 procurers and 0 suppliers have been included in NBD Trade Data.
| Year | Import/Export | Partner Count | Category Count | Region Count | Entries Total | Total Value |
|---|---|---|---|---|---|---|
| 2025 | Export | 3 | 2 | 3 | 8 | 0 |
| 2024 | Export | 3 | 1 | 3 | 12 | 0 |
| 2023 | Export | 6 | 29 | 5 | 199 | 0 |
| 2022 | Export | 9 | 27 | 7 | 164 | 0 |
| 2021 | Export | 7 | 15 | 5 | 64 | 0 |
Become a member: Inquire the Trade data, download the trade data!
Using NBD Trade Data can help the users comprehensively analyze the main trade regions of LIPOMED AG , check the customs import and export records of this company in NBD Trade Data System till now, master the upstream and downstream procurers and suppliers of this company, find its new commodities procured or supplied, search the contact information of LIPOMED AG and the procurement decision maker's E-mail address. NBD Trade Data System is updated once every three days. At present, the latest trade data of this company have been updated until 2025-11-20.
Recent customs import and export records of LIPOMED AG are as follows:
| Date | Imp & Exp | HS CODE | Product Description | Country | Imp or Exp Company | Details |
|---|---|---|---|---|---|---|
| 2025-11-20 | Export | 3004902400 | D.O. 1044/25. DESCRIPCION MINIMA DE MEDICAMENTO PARA USO HUMANO SEGUN LA RESOLUCION 057 DEL 2015: PRODUCTO: MEDICAMENTO PARA USO HUMANO (LITAK¿; 200 PACKS/PAQUETES/ENVASES). ** NOMBRE COMERCIAL: LITAK¿ 10 MG/5 ML. ** PRINCIPIO ACTIVO: CLADRIBINA 2,0 MG POR CADA 1 ML DE SOLUCION. ** CONCENTRACION DEL PRINCIPIO ACTIVO: 2,0 MG POR CADA MILILITRO DE SOLUCION EN LIQUIDOS (200 VIALES DE 10 MG/5 ML). ** INDICACIONES TERAPEUTICAS: PARA EL TRATAMIENTO DE LEUCEMIA DE CELULAS PILOSAS, ALTERNATIVO EN EL TRATAMIENTO DE LINFOMA NO HODGKIN Y LEUCEMIA LINFOCITICA CRONICA. ** FORMA FARMACEUTICA: SH Y SOLUCIONES. ** TIPO DE EMPAQUE: CAJAPOR 1 VIAL/AMPOLLA DE VIDRIO TIPO 1 POR 5 ML. ** USO: HUMANO (VIA DE ADMINISTRACION SUBCUTANEA CON FORMULA FACULTATIVA). ** MARCA: LITAK Y. /// OTRAS CARACTERISTIC | COLOMBIA | Z***. | More |